{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:56:57Z","timestamp":1764997017077},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2458-14-676","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:29:52Z","timestamp":1404347392000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Quality of life in individuals living with HIV\/AIDS attending a public sector antiretroviral service in Cape Town, South Africa"],"prefix":"10.1186","volume":"14","author":[{"given":"Mweete D","family":"Nglazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sacha J","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel A","family":"Dave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi S","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle V","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,3]]},"reference":[{"key":"6841_CR1","volume-title":"Report on the global AIDS rpidemic 2013. Joint United Nations Programme on HIV\/AIDS","author":"UNAIDS","year":"2013","unstructured":"UNAIDS: Report on the global AIDS rpidemic 2013. Joint United Nations Programme on HIV\/AIDS. 2013, http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2013\/gr2013\/UNAIDS_Global_Report_2013_en.pdf ,"},{"key":"6841_CR2","volume-title":"Global update on HIV treatment 2013: results, impact and opportunities: WHO report in partnership with UNICEF and UNAIDS","author":"World Health Organization","year":"2013","unstructured":"World Health Organization: Global update on HIV treatment 2013: results, impact and opportunities: WHO report in partnership with UNICEF and UNAIDS. 2013, Geneva: World Health Organization, http:\/\/apps.who.int\/iris\/bitstream\/10665\/85326\/1\/9789241505734_eng.pdf ,"},{"key":"6841_CR3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1097\/00002030-200109280-00010","volume":"15","author":"A Carr","year":"2001","unstructured":"Carr A, Hudson J, Chuah J, Mallal S, Law M, Hoy J, Doong N, French M, Smith D, Cooper DA: HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study. Aids. 2001, 15: 1811-1822. 10.1097\/00002030-200109280-00010.","journal-title":"Aids"},{"key":"6841_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1086\/317541","volume":"32","author":"C Hadigan","year":"2001","unstructured":"Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, Davis B, Sax P, Stanley T, Wilson PWF: Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clinical Infectious Diseases. 2001, 32: 130-139. 10.1086\/317541.","journal-title":"Clinical Infectious Diseases"},{"key":"6841_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1463-1326.2007.00760.x","volume":"10","author":"RA Bradbury","year":"2008","unstructured":"Bradbury RA, Samaras K: Antiretroviral therapy and the human immunodeficiency virus\u2013improved survival but at what cost?. Diabetes Obes Metab. 2008, 10: 441-450. 10.1111\/j.1463-1326.2007.00760.x.","journal-title":"Diabetes Obes Metab"},{"key":"6841_CR6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/QAI.0b013e318158c0a6","volume":"46","author":"E Mutimura","year":"2007","unstructured":"Mutimura E, Stewart A, Rheeder P, Crowther NJ: Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007, 46: 451-455. 10.1097\/QAI.0b013e318158c0a6.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"6841_CR7","first-page":"25","volume":"10","author":"J Igumbor","year":"2013","unstructured":"Igumbor J, Stewart A, Holzemer W: Comparison of the health-related quality of life, CD4 count and viral load of AIDS patients and people with HIV who have been on treatment for 12 months in rural South Africa. Sahara J. 2013, 10: 25-31.","journal-title":"Sahara J"},{"key":"6841_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1442-2018.2008.00410.x","volume":"10","author":"PA McInerney","year":"2008","unstructured":"McInerney PA, Ncama BP, Wantland D, Bhengu BR, McGibbon C, Davis SM, Corless IB, Nicholas PK: Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa. Nurs Health Sci. 2008, 10: 266-272. 10.1111\/j.1442-2018.2008.00410.x.","journal-title":"Nurs Health Sci"},{"key":"6841_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1758-2652-12-5","volume":"12","author":"J Pitt","year":"2009","unstructured":"Pitt J, Myer L, Wood R: Quality of life and the impact of drug toxicities in a South African community-based antiretroviral programme. J Int AIDS Soc. 2009, 12: 5-10.1186\/1758-2652-12-5.","journal-title":"J Int AIDS Soc"},{"key":"6841_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2458-7-244","volume":"7","author":"GM Louwagie","year":"2007","unstructured":"Louwagie GM, Bachmann MO, Meyer K, Booysen FR, Fairall LR, Heunis C: Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study. BMC Public Health. 2007, 7: 244-10.1186\/1471-2458-7-244.","journal-title":"BMC Public Health"},{"key":"6841_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/09540120412331319714","volume":"17","author":"J Jelsma","year":"2005","unstructured":"Jelsma J, Maclean E, Hughes J, Tinise X, Darder M: An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS care. 2005, 17: 579-588. 10.1080\/09540120412331319714.","journal-title":"AIDS care"},{"key":"6841_CR12","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1080\/09540120902884034","volume":"21","author":"E Wouters","year":"2009","unstructured":"Wouters E, Van Loon F, Van Rensburg D, Meulemans H: State of the ART: clinical efficacy and improved quality of life in the public antiretroviral therapy program, Free State province, South Africa. AIDS Care. 2009, 21: 1401-1411. 10.1080\/09540120902884034.","journal-title":"AIDS Care"},{"key":"6841_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09540120903012585","volume":"22","author":"A Bhargava","year":"2010","unstructured":"Bhargava A, Booysen Fle R: Healthcare infrastructure and emotional support are predictors of CD4 cell counts and quality of life indices of patients on antiretroviral treatment in Free State Province, South Africa. AIDS Care. 2010, 22: 1-9.","journal-title":"AIDS Care"},{"key":"6841_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/QAI.0b013e318042d5fe","volume":"45","author":"K Anastos","year":"2007","unstructured":"Anastos K, Lu D, Shi Q, Tien PC, Kaplan RC, Hessol NA, Cole S, Vigen C, Cohen M, Young M, Justman J: Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr. 2007, 45: 34-42. 10.1097\/QAI.0b013e318042d5fe.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"6841_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1590\/S1413-86702009000200012","volume":"13","author":"H Domingos","year":"2009","unstructured":"Domingos H, Cunha RV, Paniago AM, Martins DM, Elkhoury EB, Souza AS: Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients. Braz J Infect Dis. 2009, 13: 130-136.","journal-title":"Braz J Infect Dis"},{"key":"6841_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.trstmh.2009.07.009","volume":"104","author":"J van Griensven","year":"2010","unstructured":"van Griensven J, Zachariah R, Rasschaert F, Mugabo J, Atte EF, Reid T: Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda. Trans R Soc Trop Med Hyg. 2010, 104: 148-153. 10.1016\/j.trstmh.2009.07.009.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl 3","key":"6841_CR17","doi-asserted-by":"publisher","first-page":"S449","DOI":"10.1086\/521112","volume":"196","author":"RA Murphy","year":"2007","unstructured":"Murphy RA, Sunpath H, Kuritzkes DR, Venter F, Gandhi RT: Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary. J Infect Dis. 2007, 196 (Suppl 3): S449-456.","journal-title":"J Infect Dis"},{"key":"6841_CR18","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1468-1293.2008.00616.x","volume":"9","author":"H Ait-Mohand","year":"2008","unstructured":"Ait-Mohand H, Bonmarchand M, Guiguet M, Slama L, Marguet F, Behin A, Amellal B, Bennai Y, Peytavin G, Calvez V, Pialoux G, Murphy R, Katlama C: Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study. HIV Med. 2008, 9: 738-746. 10.1111\/j.1468-1293.2008.00616.x.","journal-title":"HIV Med"},{"key":"6841_CR19","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3851\/IMP1664","volume":"15","author":"A Cournil","year":"2010","unstructured":"Cournil A, Coudray M, Kouanfack C, Essomba CN, Tonfack CA, Biwole-Sida M, Delaporte E, Bork K, Laurent C: Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon. Antivir Ther. 2010, 15: 1039-1043. 10.3851\/IMP1664.","journal-title":"Antivir Ther"},{"key":"6841_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1157\/13110209","volume":"129","author":"E Pedrol","year":"2007","unstructured":"Pedrol E, Martin T, del Pozo MA, Flores J, Sanz J, Carton JA, Jusdado JJ, Arazo P, Ribera E, Deig E: Efficacy and safety of a reduced-dose of stavudine in HIV-infected patients under immunological and virological stable conditions. Med Clin (Barc). 2007, 129: 361-365. 10.1157\/13110209.","journal-title":"Med Clin (Barc)"},{"key":"6841_CR21","volume-title":"Proceedings of the 2nd IAS Conference on HIV Pathogenesis and Treatment","author":"M Hanvanich","year":"2003","unstructured":"Hanvanich M, Prasanthai V, Riengchan P, Arunyingmongkol K, Intalapaporn P, Hiransuthikul N, Suankratay C, Kulwichit W: Reduction of D4T Dosage Improves Lipoatrophy Without Virologic Failure. Proceedings of the 2nd IAS Conference on HIV Pathogenesis and Treatment. 2003, Paris, Abstract no.749"},{"key":"6841_CR22","volume-title":"Proceedings of the 9th European AIDS Conference","author":"C Delpierre","year":"2003","unstructured":"Delpierre C, Cuzin L, Alvarez M, Khatibi S, Bonnet E, Obadia M, Massip P: Lowering stavudine dosages does not compromise anti-viral efficacy in HIV-1 infected patients. Proceedings of the 9th European AIDS Conference. 2003, Abstract no.262"},{"key":"6841_CR23","volume-title":"Proceedings of the 9th European AIDS Conference","author":"C Koegl","year":"2003","unstructured":"Koegl C, Wolf E, Postel N, Buchberger A, Ruemmelein N, Jaegel-Guedes E, Jaeger H: Low Dose Stavudine: As Effective as Standard Dose but Less Side Effects. Proceedings of the 9th European AIDS Conference. 2003, Abstract no.284"},{"key":"6841_CR24","volume-title":"Proceedings of the 3rd IAS Conference on HIV Pathogenesis and Treatment","author":"A Urbina","year":"2005","unstructured":"Urbina A, Jibilian A, Nibbe Y, Maa JF, Wang S: Long Term Use of Low dose Stavudine is Effective and Well Tolerated. Proceedings of the 3rd IAS Conference on HIV Pathogenesis and Treatment. 2005, Abstract no. TuPe2.2B31"},{"key":"6841_CR25","volume-title":"Proceedings of the 3rd IAS Conference on HIV Pathogenesis and Treatment","author":"E Ribera","year":"2005","unstructured":"Ribera E, Paradi\u00f1eiro JC, Domingo P, Sauleda S, Luque S, Garcia-Arumi E, Feijoo M, Fontanet A, Falco V, Crespo M, Ocana I, Sureda D, Planas M, Pahissa A: A Randomized Study Comparing the Efficacy and Tolerability of Lowdose versus Standard-dose Stavudine in Antiretroviral-na\u00efve patients (ETOX Study). Proceedings of the 3rd IAS Conference on HIV Pathogenesis and Treatment. 2005, Abstract no. TuPe2.4 C10"},{"key":"6841_CR26","volume-title":"Antiretroviral therapy for HIV infection in adults and adoloscents","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Antiretroviral therapy for HIV infection in adults and adoloscents. 2010, Geneva: World Health Organization"},{"key":"6841_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK: Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. Jama. 2004, 292: 191-201. 10.1001\/jama.292.2.191.","journal-title":"Jama"},{"key":"6841_CR28","volume-title":"March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection:Recommendations for a public health approach","author":"World Health Organization","year":"2014","unstructured":"World Health Organization: March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection:Recommendations for a public health approach. 2014, Geneva: World Health Organization, http:\/\/apps.who.int\/iris\/bitstream\/10665\/104264\/1\/9789241506830_eng.pdf ,"},{"key":"6841_CR29","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1097\/QAI.0b013e31822a9f8d","volume":"58","author":"G Jouquet","year":"2011","unstructured":"Jouquet G, Bygrave H, Kranzer K, Ford N, Gadot L, Lee J, Hilderbrand K, Goemaere E, Vlahakis N, Trivino L, Makakole L, Cleary S: Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho. J Acquir Immune Defic Syndr. 2011, 58: e68-74. 10.1097\/QAI.0b013e31822a9f8d.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"6841_CR30","volume-title":"National Antiretroviral Treatment Guidelines","author":"National Department of Health","year":"2004","unstructured":"National Department of Health: National Antiretroviral Treatment Guidelines. 2004, Pinetown, South Africa: Jacana Publishers"},{"key":"6841_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/QAI.0b013e318221863f","volume":"57","author":"JA Dave","year":"2011","unstructured":"Dave JA, Lambert EV, Badri M, West S, Maartens G, Levitt NS: Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients. J Acquir Immune Defic Syndr. 2011, 57: 284-289. 10.1097\/QAI.0b013e318221863f.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"6841_CR32","first-page":"55","volume-title":"Anthropometric Standardization Reference Manual","author":"GG Harrison","year":"1988","unstructured":"Harrison GG, Buskirk ER, Carter JEL, Johnston FE, Lohman TG, Pollock ML, Roche AF, Wilmore J: Skinfold Thicknesses and Measurement Technique. Anthropometric Standardization Reference Manual. Edited by: Lohman TG, Roche AF, Martorel R. 1988, 55-80. 2","edition":"2"},{"key":"6841_CR33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/16070658.2009.11734233","volume":"22","author":"E Venter","year":"2009","unstructured":"Venter E, Gericke GJ, Bekker PJ: Nutritional status, quality of life and CD4 cell count of adults living with HIV\/AIDS in the Ga-Rankuwa area (South Africa). S Afr J Clin Nutr. 2009, 22: 124-129.","journal-title":"S Afr J Clin Nutr"},{"key":"6841_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1079\/BJN19740060","volume":"32","author":"JV Durnin","year":"1974","unstructured":"Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72\u00a0years. Br J Nutr. 1974, 32: 77-97. 10.1079\/BJN19740060.","journal-title":"Br J Nutr"},{"key":"6841_CR35","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1590\/S0004-27302007000600013","volume":"51","author":"LR Sampaio","year":"2007","unstructured":"Sampaio LR, Simoes EJ, Assis AM, Ramos LR: Validity and reliability of the sagittal abdominal diameter as a predictor of visceral abdominal fat. Arq Bras Endocrinol Metabol. 2007, 51: 980-986. 10.1590\/S0004-27302007000600013.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"6841_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/00005650-199907000-00007","volume":"37","author":"X Badia Llach","year":"1999","unstructured":"Badia Llach X, Herdman M, Schiaffino A: Determining correspondence between scores on the EQ-5D \u201cthermometer\u201d and a 5-point categorical rating scale. Med Care. 1999, 37: 671-677. 10.1097\/00005650-199907000-00007.","journal-title":"Med Care"},{"key":"6841_CR37","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.1086\/318492","volume":"32","author":"T Delate","year":"2001","unstructured":"Delate T, Coons SJ: The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus. Clin Infect Dis. 2001, 32: E47-52. 10.1086\/318492.","journal-title":"Clin Infect Dis"},{"key":"6841_CR38","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40265-013-0040-4","volume":"73","author":"H Gakhar","year":"2013","unstructured":"Gakhar H, Kamali A, Holodniy M: Health-related quality of life assessment after antiretroviral therapy: a review of the literature. Drugs. 2013, 73: 651-672. 10.1007\/s40265-013-0040-4.","journal-title":"Drugs"},{"key":"6841_CR39","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection:Recommendations for a public health approach June 2013","author":"World Health Organization","year":"2013","unstructured":"World Health Organization: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection:Recommendations for a public health approach June 2013. 2013, Geneva: World Health Organization, http:\/\/apps.who.int\/iris\/bitstream\/10665\/85321\/1\/9789241505727_eng.pdf ,"},{"key":"6841_CR40","volume-title":"Clinical Guidelines for the Management of HIV&AIDS in Adults and Adolescents","author":"National Department of Health","year":"2010","unstructured":"National Department of Health: Clinical Guidelines for the Management of HIV&AIDS in Adults and Adolescents. 2010, Pretoria: National Department of Health"},{"key":"6841_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-7525-5-5","volume":"5","author":"WC Mathews","year":"2007","unstructured":"Mathews WC, May S: EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care. Health Qual Life Outcomes. 2007, 5: 5-10.1186\/1477-7525-5-5.","journal-title":"Health Qual Life Outcomes"},{"key":"6841_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/QAI.0b013e3181a4f00d","volume":"51","author":"AH Anis","year":"2009","unstructured":"Anis AH, Nosyk B, Sun H, Guh DP, Bansback N, Li X, Barnett PG, Joyce V, Swanson KM, Kyriakides TC, Holodniy M, Cameron DW, Brown ST, OPTIMA Team1: Quality of life of patients with advanced HIV\/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events. J Acquir Immune Defic Syndr. 2009, 51: 631-639. 10.1097\/QAI.0b013e3181a4f00d.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-676.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-14-676\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T12:05:24Z","timestamp":1498133124000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-14-676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,3]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["6841"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-14-676","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,3]]},"article-number":"676"}}